Arbutus Biopharma (NASDAQ: ABUS) reported Q1 EPS of ($0.36), versus ($0.34) reported last year. Revenue for the quarter came in at $1.4 thousand, versus $200 million reported last year.

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.